Samþykkt | Titill | Höfundur(ar) |
---|---|---|
13.4.2022 | Formulation development for first-order release caffeine tablets | Sólveig Axelsdóttir 1992-; Guðrún Lóa Sverrisdóttir 1999-; Anamaría Salomé A. Palma 1999-; Petra Ósk Guðbjargardóttir 1998- |
18.4.2024 | Serum PP13, sFlt-1, and PlGF levels in the third trimester and after birth, with a summary of PP13 levels for different periods of gestation | Sólveig Axelsdóttir 1992- |